| Stage | ARXS | % of rev | LOAR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $564M | 100.00% | $172M | 100.00% | ARXS ×3.29 |
| Gross profit | $306M | 54.27% | $91M | 53.15% | ARXS +1.1pp |
| Operating income | $133M | 23.66% | $42M | 24.39% | LOAR +0.7pp |
| Pre-tax income | $120M | 21.23% | $22M | 12.73% | ARXS +8.5pp |
| Net income | $84M | 14.84% | $17M | 9.76% | ARXS +5.1pp |
| Stage | ARXS | LOAR | Gap · A − B |
|---|---|---|---|
| Revenue | $564M100.00% | $172M100.00% | ARXS ×3.29 |
| Gross profit | 54.27%$306M | 53.15%$91M | ARXS +1.1pp |
| Operating income | 23.66%$133M | 24.39%$42M | LOAR +0.7pp |
| Pre-tax income | 21.23%$120M | 12.73%$22M | ARXS +8.5pp |
| Net income |
| 14.84%$84M |
| 9.76%$17M |
| ARXS +5.1pp |
No disclosed counterparties: ARXS, LOAR.